Antibacterial Therapy and Newer Agents, An Issue of Infectious Disease Clinics. Este artículo no está disponible.
Idioma: inglés
Editorial: Elsevier Health Sciences, 2009
- Tapa dura
- Nuevo

Librería: THE SAINT BOOKSTORE, Southport, Reino UnidoTHE SAINT BOOKSTORE
Vendedor de 5 estrellas
Vendedor de IberLibro desde 14 de junio de 2006
No disponible
Tapa dura
Condición: Nuevo
EUR 82,60
Descripción del artículo del vendedor
New copy - Usually dispatched within 4 working days.
N° de ref. del artículo B9781437712322
- Título
- Antibacterial Therapy and Newer Agents, An Issue of Infectious Disease Clinics
- Autor
- Keith S. Kaye
- Editorial
- Elsevier Health Sciences
- Año de publicación
- 2009
- Estado
- New
- Encuadernación
- Hardback
- Idioma
- inglés
- ISBN 10
- 1437712320
- ISBN 13
- 9781437712322
- Peso del artículo
- 620 gramos
Infectious diseases is a rapidly changing field in which new organisms emerge, previously identified organisms develop resistance to treatment, and infections that had previously almost disappeared become resurgent. These factors require rapid changes in therapeutic approaches, especially in the use of antimicrobial agents. This issue covers antibiotics in specific populations (children, the elderly, and patients with renal failure), antimicrobial resistance, and new drugs in several classes, including macrolides, fluoroquinolones, beta-lactam antibiotics, and agents for gram-positive infections.
“Sinopsis” puede pertenecer a otra edición de este título.
Reseña del editor
Infectious diseases is a rapidly changing field in which new organisms emerge, previously identified organisms develop resistance to treatment, and infections that had previously almost disappeared become resurgent. These factors require rapid changes in therapeutic approaches, especially in the use of antimicrobial agents. This issue covers antibiotics in specific populations (children, the elderly, and patients with renal failure), antimicrobial resistance, and new drugs in several classes, including macrolides, fluoroquinolones, beta-lactam antibiotics, and agents for gram-positive infections.
“Acerca de” puede pertenecer a otra edición de este título.